TEC
AGN

Tiger Eye Capital’s Allergan Inc AGN Stock Holding History

Tiger Eye Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-84,358
Closed -$17.9M – 70
2014
Q4 		$17.9M Buy
+84,358
New +$16.8M 1.42% 32
2014
Q3 		– Sell
-12,420
Closed -$2.1M – 69
2014
Q2 		$2.1M Buy
+12,420
New +$1.93M 0.22% 40

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Tiger Eye Capital's AGN Position: Q1 2015 in Review

Tiger Eye Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 84,358 shares — an estimated $17.9M sold.

Tiger Eye Capital first reported a position in AGN in Q2 2014 and held it in 2 quarters. The position peaked at $17.9M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Tiger Eye Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Tiger Eye Capital sold 84,358 Allergan Inc shares in Q1 2015, an estimated $17.9M.
  • Tiger Eye Capital first reported a position in Allergan Inc in Q2 2014 and held it in 2 quarters.
  • Tiger Eye Capital's Allergan Inc position peaked at $17.9M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Tiger Eye Capital's 13F filing for Q1 2015, filed 13 May 2015.